SPG vs TNGX · rev $3.55B vs $5.36B cap
SPG (SPG) versus Tango Therapeutics Inc (TNGX) — a side-by-side from cached financials, not a winner call.
SPG (SPG) common stock.
Tango Therapeutics Inc (TNGX) is a biotechnology company listed on NASDAQ.
Latest reported SPG revenue for 2026-06-30 was $3.55B. Net income was $1.14B. SPG currently screens at market cap $0.
Latest reported TNGX revenue for 2026-06-30 was $0. Net income was -$100.9M. TNGX currently screens at market cap $5.36B.
SPG currently screens at market cap $0. TNGX currently screens at market cap $5.36B.
Not investment advice. Open the SPG and TNGX stock pages for the full models.
Not investment advice.